Redeye lowers its valuation of Clavister following weaker than expected Q2 revenue figures. We cut our short-term revenue forecasts, which are partly mitigated by positive cost adjustments, as cost and cash management exceeded expectations for the second consecutive quarter. Recognised revenue disappointments were offset by strong order intake and billings, which should support growth in the coming quarters.